Completed PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT01561846

Cheese Intake,CLA and Hypercholesterolemia (CASU)

Randomized, Double Blind, Controlled, Cross Over Clinical Trial on Intake of CLA Enriched Cheese in Hypercholesterolemic Patients

Sponsor: Azienda Ospedaliera Brotzu

Conditions Modifications of Enocannabinoid Levels Modifications of LDL Cholesterol

Interventions CLA enriched cheese

Updated 4 times since 2017 Last updated: Mar 22, 2012 Started: Jun 30, 2008 Primary completion: Dec 31, 2008 Completion: Mar 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Modifications of Enocannabinoid Levels and Modifications of LDL Cholesterol, this trial is completed. The trial is conducted by Azienda Ospedaliera Brotzu and has accumulated 4 data snapshots since 2008. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Jan 2017 — Jan 2021 [monthly]

Completed PHASE1_PHASE2

First recorded

Jun 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Azienda Ospedaliera Brotzu
University of Cagliari

Data source: Azienda Ospedaliera Brotzu

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cagliari, Italy